A straightforward chiral pool synthesis for the first fluorinated calystegin is described. Key steps of this synthesis include an ultrasound-assisted Zn-mediated tandem ring opening reaction followed by a Grubbs' catalyst-mediated ring closure metathesis reaction. The target compound is a selective and competitive inhibitor for a β -glycosidase.
Introduction
Calystegins [1] are bicyclic alkaloids that hold structural features derived from the nortropane skeleton; they are poly-hydroxylated and represent a group of plant secondary metabolites with structural closeness to sugars. Like iminosugars they display strong and/or specific competitive inhibitory activity [2 -4] , and they have been suggested as chemotherapeutic drugs to treat viral diseases [5, 6] and metabolic disorders [7, 8] (e. g. diabetes); quite recently, they have been suggested [9] as pharmacoperones for the treatment of protein folding disorders.
Naturally occurring calystegins have been obtained from their natural sources [1] by more or less tedious extraction processes; only a few of them have become available by total synthesis [10 -22] . No functional derivatives of calystegins have been prepared so far. 0932-0776 / 10 / 0400-0445 $ 06.00 c 2010 Verlag der Zeitschrift für Naturforschung, Tübingen · http://znaturforsch.com Previously, the incorporation of a fluorine substituent has been shown [23] to be of advantage both for an improved activity, higher bioavailability and a retarded metabolism of several drugs. Therefore, we became interested in the synthesis of a fluorinated calystegin analog. Thus, we report the first total synthesis of fluorinated calystegin.
Results and Discussion
The synthesis of our target molecule, 3-deoxy-3-fluoro-calystegin B 2 , was planned as a chiral pool approach starting from the well-known [24, 25] 3-deoxy-3-fluoro-α-D-gluco-furanose 1 (Scheme 1) that was easily transformed [26] into the corresponding pyranosidic glycosides 2 and 3. Treatment of 2 with triphenylphosphane/imidazole/iodine [27] followed by an ultrasound-assisted tandem reaction [28] of 4 gave the diene 5. In a similar way, from 3 the iodo-compound 6 was obtained that gave 5 in the tandem reaction. Compound 5 was carbobenzoxylated (Scheme 2) in almost quantitative yield to afford 7 which was allowed to react in a Grubbs' (2 nd generation) catalystmediated ring closure metathesis [28] to afford 94 % of the cycloheptene 8. Hydroboration [29] of this cycloheptene using BH 3 ·THF followed by oxidative workup with sodium hydroxide/hydrogen peroxide provided the cycloheptanols 9 and 10. PCC-oxidation of 9 gave 77 % of the cycloheptanone 11 which was finally hydrogenated in the presence of Pd/C to yield the 3-fluoro-calystegine B 2 analog 12.
The inhibitory activity of this fluorodeoxy-calystegin against several β -glycosidases was investigated using a 4-nitrophenyl-D-glucopyranoside assay [30] . In analogy to naturally occurring calystegin B 2 , its 3-fluoro analog 12 shows no inhibition against the α-glycosidase from yeast but is a competitive inhibitor of the β -glucosidase from almonds showing a K i = 82 µ M. Its inhibitory activity is lower compared with calystegin B 2 (K i = 5.9 µ M), proving that a hydroxyl group at position C-3 is necessary for a tight binding of the calystegin-based inhibitor into the active site of the β -glycosidases.
Experimental Section

General methods
Melting points are uncorrected (Leica hot stage microscope). Optical rotations were obtained using a PerkinElmer 341 polarimeter (1 cm micro cell). NMR spectra were recorded using the Varian spectrometers Gemini 200, Gemini 2000 or Unity 500 (δ given in ppm, J in Hz, internal Me 4 Si or internal CCl 3 F), IR spectra (film or KBr pellet) on a Perkin-Elmer FT-IR spectrometer Spectrum 1000. Mass spectra were taken on an Intectra GmbH AMD 402 (electron impact, 70eV) or on a Thermo Electron Finnigan LCQ (electrospray, voltage 4.5 kV, sheath gas nitrogen) instrument. For elemental analysis a Foss-Heraeus Vario EL instrument was used. TLC was performed on silica gel (Merck 5554, detection by UV absorption or by treatment with a solution of 10 % sulfuric acid, ammonium molybdate and cerium(IV) sulfate) followed by gentle heating. The solvents were dried according to usual procedures.
Hydrolysis of 1
A suspension of 1 (3.86 g, 14.7 mmol) in water (25 mL) and concentrated H 2 SO 4 (2.0 mL) was stirred for 24 h at 25 • C. After addition of sodium bicarbonate (6.06 g), the solvent was evaporated under reduced pressure, and the remaining solid was suspended in abs. methanol. The slurry was filtered, and the filtrate was concentrated. The resulting mixture of α-and β -pyranoses (colorless solid) was dissolved in abs. methanol and cooled to 0 • C. Methanolic HCl was added dropwise, and the mixture was stirred under reflux for 8 h; the solvent was evaporated, the crude product was dried over potassium hydroxide (desiccator), and then it was dissolved in pyridine (50 mL). Trityl chloride (6.00 g, 21.5 mmol) and DMAP (0.40 g, 3.3 mmol) were added, and the resulting solution was stirred at 25 • C for 16 h. The sol-vent was evaporated, ether (100 mL) was added, and the organic phase was extracted with water. The aqueous phase was washed with ether (3 × 100 mL), and the combined organic phases were evaporated. The remaining residue was subjected to chromatography (silica gel, n-hexane-ethyl acetate = 50:50) to afford an epimeric mixture of the corresponding methyl glycosides (1.4 g). To a solution of this mixture (1.40 g, 3.2 mmol) in dry DMF (50 mL), sodium hydride (55 % in mineral oil, 700 mg, 16.00 mmol) was slowly added, and stirring at 0 • C was continued for 15 min, followed by stirring at 25 • C for 15 min. Then benzyl bromide (2.27 mL, 19.00 mmol) was added and stirring continued at 25 • C for another 3 h. Methanol (30 mL) was carefully added, and the solvents were removed under reduced pressure. The oily residue was dissolved in diethyl ether (150 mL) and washed with water (100 mL). The aqueous phase was extracted with diethyl ether. The combined organic phases were dried (MgSO 4 ), and the solvents were evaporated. The remaining solid was dissolved in methanol (70 mL) and dichloromethane (60 mL), catalytic amounts of p-TsOH were added, and the mixture was stirred at 25 • C for 1 d. After neutralization (conc. aqueous ammonium hydroxide), the solvents were removed in vacuo. The residue was dissolved in ether (150 mL) and washed with water and brine (100 mL each). After drying (MgSO 4 ), the solvent was removed and the residue subjected to chromatography (silica gel, n-hexane-ethyl acetate 5:3) to afford 2 and 3 as colorless oils. ν = 3475m, 3064m,  2919m, 1692w, 1572w, 1497m, 1454m, 1369m, 1327w,  1195m, 1074s, 1027s, 905m, 738s, 698s, 606m 
Methyl 2,4-di-O-benzyl-3-deoxy-3-fluoro-β -D-glucopyranoside (2)
CDCl 3 ): δ = −188.94 (ddd, 1 F, 3 J F,4 = 13.3, 3 J F,
Methyl 2,4-di-O-benzyl-3-deoxy-3-fluoro-α-D-glucopyranoside (3)
Colorless
Methyl 2,4-di-O-benzyl-3,6-dideoxy-3-fluoro-6-iodo-β -Dglucopyranoside (4)
To a solution of 4 (1.37 g, 3.72 mmol) in abs. toluene (50 mL) containing triphenylphosphane (2.14 g, 8.32 mmol) and imidazole (1.14 g, 16.75 mmol), iodine (1.89 g, 7.45 mmol) was added in several portions. After stirring at 95 • C for 2 h, the reaction mixture was decanted and the remaining oil washed with ether (3 × 100 mL). The combined organic phases were evaporated, and the remaining residue was subjected to chromatography (silica gel, nhexane-ethyl acetate 85:15) to afford 4 (1. ν = 3441m, 3088w, 3064w, 3032w, 2941w,  2920m, 2880w, 1630w, 1497w, 1454m, 1403w, 1391w,  1370w, 1319w, 1266w, 1246w, 1213w, 1200m, 1173m,  1117s, 1081s, 1040m, 1028m, 1012m, 992m, 912w, 816w , H-6 ), 3.12 (m,  1 H, H-5 ). - 13 
(3R, 4S, 5S, 6R) 6-[(N-Benzyl)amino]-3,5-bis(benzyloxy)-4-fluoro-1,8-nonadiene (5)
From 4: According to the above procedure using 4 (1.51 g, 3.11 mmol), activated Zn powder (2.03 g, 31.1 mmol), benzylamine (1.70 mL, 15.60 mmol), and allylbromide (0.81 mL, 9.33 mmol), product 5 (819 mg, 57.0 %) was obtained as a colorless oil.
From 6: To a solution of 6 (920 mg, 1.89 mmol) in dry THF (50 mL), activated Zn powder (1.23 g, 18.90 mmol) was added and the mixture put in an ultrasound cleaning bath for 20 min. At a temperature of 40 • C benzylamine (1.03 mL, 9.46 mmol) was slowly added, and the treatment with ultrasound was continued for another 8 h. Allylbromide (0.49 mL, 5.68 mmol) was added, and ultrasound was applied for another 4 h. The mixture was cooled to 25 • C and filtered over a small layer of silica gel (5 cm). The filtrate was diluted with ethyl acetate (5 × 100 mL) and dried, and the solvents were evaporated. The residue was subjected to chromatography (silica gel, n-hexane-ethyl acetate 
Methyl 2,4-di-O-benzyl-3,6-dideoxy-3-fluoro-6-iodo-a-Dglucopyranoside (6)
To a solution of 3 (950 mg, 2.52 mmol) in abs. toluene (50 mL) containing triphenylphosphane (1.44 g, 5.55 mmol) and imidazole (1.27 g, 18.66 mmol), iodine (1.27 g, 5.01 mmol) was added in several portions. After stirring at 95 • C for 2 h the reaction mixture was decanted, and the remaining oil washed with ether (3 × 100 mL). The combined organic phases were evaporated, and the remaining residue was subjected to chromatography (silica gel, n-hexane-ethyl 
